Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kerrie Faia
Duvelisib, an Oral Dual PI3K-δ,γ Inhibitor, Shows Clinical and Pharmacodynamic Activity in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma in a Phase 1 Study
American Journal of Hematology
Hematology
Related publications
Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
A Phase I/Ii Study of Rituximab and Etanercept in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
An Improved Benefit-Risk Profile of Duvelisib in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Received 2 or More Prior Therapies
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The PI3Kδ INHIBITOR ME-401 ± RITUXIMAB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Impacts of Zanubrutinib on Immune Cells in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Clinical Pathways in Chronic Lymphocytic Leukemia: Challenges and Solutions
American Journal of Hematology
Hematology
Activity of the Janus Kinase Inhibitor Ruxolitinib in Chronic Lymphocytic Leukemia: Results of a Phase II Trial
Haematologica
Hematology
The Prognostic Significance of Cytopenia in Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma
British Journal of Haematology
Hematology
